MYC and cancer: In cancer cells, the transcription factor Myc causes overexpression of miRNA-186 and miR-9, which inhibit E-cadherin, as well as PRS-19, while inhibiting NDRG2 expression, ultimately leading to epithelial-mesenchymal transition (EMT) in the cancer cell [43].